Pfizer's Growth Potential and Strategic Focus Justify Buy Rating Amid Healthcare Policy Shifts

TipRanks4minutes ago · Ratings

Citi Maintains Pfizer(PFE.US) With Hold Rating

Futu News14minutes ago · Ratings

Market Chatter: Pfizer CEO Bourla Downplays Dispute With Activist Investor Starboard Value

MT Newswires37minutes ago

Trump Looms Large Over Stock Markets. Why Chips, -2-

Barron's39minutes ago

Express News | BioNTech SE - for 2025, Co & Pfizer Expect Largely Stable Vaccination Rates & Market Share in U.S. and Revenue Phasing Similar to 2024

Breakings19:48

Analysts Conflicted on These Healthcare Names: Xencor (XNCR) and Pfizer (PFE)

TipRanks19:40 · Ratings